Multiple biomarker expression in circulating tumor cells (CTCs) from locally advanced/inflammatory (LA/IBC) and metastatic breast cancer (MBC) patients (pts)

被引：0
|
作者：
Bruce, R. H. [1 ,2 ]
Hseih, H. B. [1 ,2 ]
Curry, D. N. [1 ,2 ]
Krivacic, R. T. [1 ,2 ]
Lazarus, N. [1 ,2 ]
Frankel, P. [1 ,2 ]
Lau, S. [1 ,2 ]
Somlo, G. [1 ,2 ]
机构：
[1] Palo Alto Res Ctr, Palo Alto, CA USA
[2] City Hope Comprehens Canc Ctr, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1092
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Genome-wide copy number analysis of circulating tumor cells from patients (pts) with metastatic breast cancer (MBC)
    Magbanua, M. J. M.
    Sosa, E.
    Roy, R.
    Eisenbud, L.
    Scott, J.
    Olshen, A.
    Pinkel, D.
    Rugo, H. S.
    Park, J. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [22] Apoptotic Circulating Tumor Cells (CTCs) in early and metastatic breast cancer patients
    Kallergi, Galatea
    Konstantinidis, Georgios
    Papadaki, Maria
    Agelaki, Sophia
    Mavroudis, Dimitris
    Stournaras, Christos
    Georgoulias, Vassilis
    CANCER RESEARCH, 2011, 71
  • [23] Identification of p53 Mutation in Whole Genome DNA from Single Circulating Tumor Cells (CTCs) and Primary Breast Cancers (BC) from Patients (pts) with Metastatic Breast Cancer (MBC).
    Yang, L.
    Wang, Y.
    Chu, P.
    Liu, Q.
    Hsieh, B.
    Liu, X.
    Yen, Y.
    Bruce, R.
    Somlo, G.
    CANCER RESEARCH, 2011, 71
  • [24] BONE MARROW (BM) INVOLVEMENT IS ASSOCIATED WITH HIGHER NUMBERS OF CIRCULATING TUMOR CELLS (CTCS) IN METASTATIC BREAST CANCER (MBC) PATIENTS
    Grisanti, S.
    Almici, C.
    Consoli, F.
    Montani, E.
    Amoroso, V.
    Pedersini, R.
    Vassalli, L.
    Morassi, L.
    Lucini, L.
    Simoncini, E. L.
    ANNALS OF ONCOLOGY, 2011, 22 : 42 - 42
  • [25] Detection of circulating tumor cells (CTCs) is a prognostic factor in first-line metastatic breast cancer (MBC)
    Cristofanilli, M
    Reuben, JM
    Fritsche, HA
    Hayes, DF
    Budd, TG
    Ellis, MJ
    Stopeck, A
    Miller, CM
    Matera, J
    Allard, JW
    Terstappen, LWMM
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S225 - S225
  • [26] Correlation of circulating tumor cells (CTCs) with peripheral blood leukocytes to predict outcome in metastatic breast cancer (MBC).
    De Giorgi, Ugo
    Mego, Michal
    Scarpi, Emanuela
    Giordano, Antonio
    Giuliano, Mario
    Valero, Vicente
    Alvarez, Ricardo H.
    Ueno, Naoto T.
    Cristofanilli, Massimo
    Reuben, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Enabling HER2 and androgen receptor (AR) protein expression and localization in circulating tumor cells (CTCs) of ER(+/-)HER2(-) metastatic breast cancer (MBC) patients (pts)
    Ontiveros, P.
    Landaverde, C.
    Graf, R.
    Levin, M. K.
    Hippely, S.
    Wang, Y.
    Landers, M.
    Dittamore, R.
    O'Shaughnessy, J. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [28] Features of patients (pts) with metastatic breast cancer (mBC) and a circulating tumor cell count (CTCc) of 0
    Bubis, J. A.
    Marsland, T. A.
    Justice, K. M.
    Edwords, D.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S25 - S25
  • [29] Isolation and expression profiling of circulating tumor cells (CTCs) in breast cancer patients
    Lang, JE
    Scott, JH
    Haqq, CM
    Ginzinger, D
    Esserman, LJ
    Park, JW
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S225 - S225
  • [30] Apoptosis in Circulating Tumor Cells (CTCs) of Early and Metastatic Breast Cancer Patients.
    Kallergi, G.
    Konstantinidis, G.
    Papadaki, M.
    Agelaki, S.
    Mavroudis, D.
    Stournaras, C.
    Georgoulias, V.
    CANCER RESEARCH, 2011, 71
12345